SPRO
Spero Therapeutics Inc
1.20$
-3.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Spero Therapeutics Inc (SPRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.4 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 | -17 | 5.9 | -19 | 13 | -23 | -4.0 | -18 | 17 | -8.4 | 16 | -5.4 | 20 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | – | |
| 1.9 | 2.0 | 2.0 | 2.1 | 2.2 | 1.5 | 1.6 | 0.7 | 1.0 | 1.0 | 1.1 | 0.8 | 4.0 | |
| 12 | -71 | 16 | -3.3 | 27 | -4.3 | 8.0 | -17 | 23 | -41 | 22 | 3.1 | 6.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.2 | 0.0 | – | – | – | 0.0 | – | – | – | – | – | – | – | |
| 16 | -17 | 5.9 | -19 | 13 | -23 | -4.0 | -18 | 17 | -8.4 | 16 | -5.4 | 20 | |
| 16 | -17 | 5.9 | -19 | 13 | -23 | -4.0 | -18 | 17 | -8.4 | 16 | -5.4 | 20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.